Elevated serum progesterone values at the time of ovulation induction in luteal leuprolide acetate-down-regulated GIFT cycles are associated with decreased clinical pregnancy rates

[1]  C. Shivers,et al.  Isolation, in vitro maturation, and fertilization of germinal vesicle oocytes obtained from the intact murine ovary , 1990, Journal of in Vitro Fertilization and Embryo Transfer.

[2]  G. Goldman,et al.  The impact of high progesterone levels in the follicular phase of in vitro fertilization (IVF) cycles: A comparative study , 1989, Journal of in Vitro Fertilization and Embryo Transfer.

[3]  G. Garrisi,et al.  Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality. , 1993, Fertility and sterility.

[4]  R. Legro,et al.  Pregnancy: Premature luteinization as detected by elevated serum progesterone is associated with a higher pregnancy rate in donor oocyte in-vitro fertilization , 1993 .

[5]  C. Mastroyannis.  Gamete intrafallopian transfer: ethical considerations, historical development of the procedure, and comparison with other advanced reproductive technologies. , 1993, Fertility and sterility.

[6]  P. Brinsden.  A Textbook of In Vitro Fertilization and Assisted Reproduction : The Bourn Hall Guide to Clinical and Laboratory Practice , 2005 .

[7]  R. Schenken,et al.  Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins. , 1991, The Journal of clinical endocrinology and metabolism.

[8]  T. Schlenker,et al.  Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. , 1991, Fertility and sterility.

[9]  H. Seltman,et al.  Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin‐releasing hormone agonist suppression are not predictive of pregnancy outcome , 1990, Fertility and sterility.

[10]  D. Meldrum,et al.  Leuprolide acetate lowers circulating bioactive luteinizing hormone and testosterone concentrations during ovarian stimulation for oocyte retrieval. , 1990, Fertility and sterility.

[11]  T. Nass,et al.  Improved pregnancy outcome with the addition of leuprolide acetate to gonadotropins for in vitro fertilization. , 1989, Fertility and sterility.

[12]  D. Meldrum,et al.  Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval. , 1989, Fertility and sterility.

[13]  R. Marrs,et al.  An alternate approach to controlled ovarian hyperstimulation in "poor responders": pretreatment with a gonadotropin-releasing hormone analog. , 1988, Fertility and sterility.

[14]  R. Marrs,et al.  Occurrence of a spontaneous luteinizing hormone surge in superovulated cycles--predictive value of serum progesterone. , 1988, Fertility and sterility.

[15]  C. Friedman,et al.  Follicular stimulation for in vitro fertilization using pituitary suppression and human menopausal gonadotropins. , 1987, Fertility and sterility.

[16]  R. Fleming,et al.  Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression. , 1986, Fertility and sterility.

[17]  L. Veeck.  Atlas of the human oocyte and early conceptus , 1986 .

[18]  P V Dandekar,et al.  Laboratory setup for human in vitro fertilization. , 1984, Fertility and sterility.